Treatment of primary and metastatic breast and pancreatic tumors upon intravenous delivery of a PRDM14 ‐specific chimeric siRNA /nanocarrier complex
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of primary and metastatic breast and pancreatic tumors upon intravenous delivery of a
PRDM14
‐specific chimeric
siRNA
/nanocarrier complex
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-03-30
DOI
10.1002/ijc.33579
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vivo rendezvous of small nucleic acid drugs with charge-matched block catiomers to target cancers
- (2019) Sumiyo Watanabe et al. Nature Communications
- PRDM14 is overexpressed in chronic pancreatitis prior to pancreatic cancer
- (2018) Chiharu Moriya et al. FEBS Open Bio
- Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer
- (2017) Hiroaki Taniguchi et al. Oncotarget
- The role of PRDMs in cancer: one family, two sides
- (2016) Slim Mzoughi et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Breast Cancer Genomics From Microarrays to Massively Parallel Sequencing: Paradigms and New Insights
- (2015) Charlotte K. Y. Ng et al. JNCI-Journal of the National Cancer Institute
- Breast Cancer Genomics From Microarrays to Massively Parallel Sequencing: Paradigms and New Insights
- (2015) Charlotte K. Y. Ng et al. JNCI-Journal of the National Cancer Institute
- PRDM14 Ensures Naive Pluripotency through Dual Regulation of Signaling and Epigenetic Pathways in Mouse Embryonic Stem Cells
- (2013) Masashi Yamaji et al. Cell Stem Cell
- Current challenges and opportunities in nonclinical safety testing of biologics
- (2013) Sven Kronenberg et al. DRUG DISCOVERY TODAY
- High expression of PRDM14 correlates with cell differentiation and is a novel prognostic marker in resected non-small cell lung cancer
- (2013) Tiehong Zhang et al. MEDICAL ONCOLOGY
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- Enhanced specificity of HPV16 E6E7 siRNA by RNA–DNA chimera modification
- (2011) K Yamato et al. CANCER GENE THERAPY
- Prdm14 initiates lymphoblastic leukemia after expanding a population of cells resembling common lymphoid progenitors
- (2011) E J Dettman et al. ONCOGENE
- siRNA-Based Therapy Ameliorates Glomerulonephritis
- (2010) H. Shimizu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sequence-specific regulator Prdm14 safeguards mouse ESCs from entering extraembryonic endoderm fates
- (2010) Ziyang Ma et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Origins and Mechanisms of miRNAs and siRNAs
- (2009) Richard W. Carthew et al. CELL
- PRDM14 suppresses expression of differentiation marker genes in human embryonic stem cells
- (2008) Norihiro Tsuneyoshi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- Functional dissection of siRNA sequence by systematic DNA substitution: modified siRNA with a DNA seed arm is a powerful tool for mammalian gene silencing with significantly reduced off-target effect
- (2008) Kumiko Ui-Tei et al. NUCLEIC ACIDS RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started